Treatment strategies for unresectable locally advanced non-small cell lung cancer in the real-life ESME cohort.
Fiche publication
Date publication
novembre 2021
Journal
Lung cancer (Amsterdam, Netherlands)
Auteurs
Membres identifiés du Cancéropôle Est :
Dr COUDERT Bruno, Dr DEBIEUVRE Didier, Dr SCHOTT Roland
Tous les auteurs :
Girard N, Perol M, Simon G, Audigier Valette C, Gervais R, Debieuvre D, Schott R, Quantin X, Coudert B, Lena H, Carton M, Robain M, Filleron T, Chouaid C
Lien Pubmed
Résumé
Cisplatin-based chemotherapy administered concurrently to thoracic radiation therapy is the recommended treatment for fit patients with unresectable stage III NSCLC. The aim of this study was to describe patient profiles and clinical outcomes for the different treatment strategies in a real-word setting.
Mots clés
Chemotherapy, Concurrent chemoradiotherapy, Locally advanced non-small cell lung cancer, Observational cohort, Radiotherapy, Sequential chemoradiotherapy, Unresectable non-small cell lung cancer
Référence
Lung Cancer. 2021 Nov 6;162:119-127